Company · CIK 0001933414 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Mineralys Therapeutics, Inc. · MLYS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 9:49 pm EDT | Brian Taylor SlingsbyDirector | 104,320 | $28.81 | $3,005,303 | 7,805,718 | −1.32% | |
| Sep 21, 2026 SForm 4 → | Sep 22, 6:48 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | $28.12 | $209,136 | 38,400 | −16.2% | 10b5-1 |
| Sep 21, 2026 MForm 4 → | Sep 22, 6:48 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | $13.24 | $98,479 | 45,838 | — | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 17, 5:41 pm EDT | Daphne KarydasDirector | 3,000 | $28.58 | $85,740 | 6,200 | −32.6% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 5:41 pm EDT | Daphne KarydasDirector | 3,000 | $12.02 | $36,060 | 9,200 | — | 10b5-1 |
| Aug 21, 2026 SForm 4 → | Aug 25, 5:16 pm EDT | Eric WarrenChief Commercial Officer | 7,437 | $25.98 | $193,189 | 38,400 | −16.2% | 10b5-1 |
| Aug 21, 2026 MForm 4 → | Aug 25, 5:16 pm EDT | Eric WarrenChief Commercial Officer | 7,437 | $13.24 | $98,466 | 45,837 | — | 10b5-1 |
| Aug 10, 2026 AForm 4 → | Aug 12, 7:33 pm EDT | James J. Ferguson IIIChief Medical Officer | 102,400 | — | — | 102,400 | — | |
| Aug 10, 2026 SForm 4 → | Aug 12, 7:33 pm EDT | David Malcom RodmanChief Medical Officer | 2,170 | $27.09 | $58,785 | 51,384 | −4.05% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 7:33 pm EDT | David Malcom RodmanChief Medical Officer | 2,170 | $16.00 | $34,720 | 53,554 | — | 10b5-1 |
| Jul 21, 2026 SForm 4 → | Jul 23, 6:39 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | $26.87 | $199,885 | 38,400 | −16.2% | 10b5-1 |
| Jul 21, 2026 MForm 4 → | Jul 23, 6:39 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | $13.24 | $98,479 | 45,838 | — | 10b5-1 |
| Jul 17, 2026 SForm 4 → | Jul 20, 9:00 pm EDT | David Malcom RodmanChief Medical Officer | 416 | $26.53 | $11,036 | 51,384 | −0.80% | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 20, 9:00 pm EDT | David Malcom RodmanChief Medical Officer | 416 | $15.44 | $6,423 | 51,800 | — | 10b5-1 |
| Jul 13, 2026 SForm 4 → | Jul 15, 8:58 pm EDT | Jon CongletonChief Executive Officer, Director | 10,700 | $27.24 | $291,441 | 603,621 | −1.74% | 10b5-1 |
| Jul 13, 2026 SForm 4 → | Jul 15, 8:58 pm EDT | David Malcom RodmanChief Medical Officer | 20,407 | $27.28 | $556,671 | 51,384 | −28.4% | 10b5-1 |
| Jul 13, 2026 MForm 4 → | Jul 15, 8:58 pm EDT | David Malcom RodmanChief Medical Officer | 14,058 | $7.28 | $102,365 | 71,791 | — | 10b5-1 |
| Jul 9, 2026 SForm 4 → | Jul 10, 7:15 pm EDT | David Malcom RodmanChief Medical Officer | 2,171 | $30.30 | $65,781 | 57,733 | −3.62% | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 10, 7:15 pm EDT | David Malcom RodmanChief Medical Officer | 2,171 | $16.00 | $34,736 | 59,904 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jun 30, 6:41 pm EDT | Jon CongletonChief Executive Officer, Director | 75,000 | $26.14 | $1,960,601 | 614,321 | −10.9% | 10b5-1 |
| Jun 26, 2026 SForm 4 → | Jun 30, 6:41 pm EDT | Eric WarrenChief Commercial Officer | 104,124 | $25.90 | $2,696,322 | 38,400 | −73.1% | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 6:41 pm EDT | Eric WarrenChief Commercial Officer | 104,124 | $13.24 | $1,378,602 | 142,524 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 17, 9:18 pm EDT | Daphne KarydasDirector | 3,000 | $25.00 | $75,000 | 6,200 | −32.6% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 17, 9:18 pm EDT | Daphne KarydasDirector | 3,000 | $12.02 | $36,060 | 9,200 | — | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 9:18 pm EDT | David Malcom RodmanChief Medical Officer | 14,474 | $24.19 | $350,087 | 57,095 | −20.2% | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 17, 9:18 pm EDT | David Malcom RodmanChief Medical Officer | 8,126 | $12.55 | $101,947 | 61,679 | — | 10b5-1 |
| Jun 10, 2026 SForm 4 → | Jun 12, 6:04 pm EDT | David Malcom RodmanChief Medical Officer | 8,519 | $24.20 | $206,151 | 63,443 | −11.8% | 10b5-1 |
| Jun 10, 2026 MForm 4 → | Jun 12, 6:04 pm EDT | David Malcom RodmanChief Medical Officer | 8,519 | $4.88 | $41,577 | 69,792 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 MForm 4 → | Sep 22, 6:48 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | — | — | 230,563 | — | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 5:41 pm EDT | Daphne KarydasDirector | 3,000 | — | — | 35,000 | — | 10b5-1 |
| Aug 21, 2026 MForm 4 → | Aug 25, 5:16 pm EDT | Eric WarrenChief Commercial Officer | 7,437 | — | — | 238,001 | — | 10b5-1 |
| Aug 10, 2026 AForm 4 → | Aug 12, 7:33 pm EDT | James J. Ferguson IIIChief Medical Officer | 135,000 | — | — | 135,000 | — | |
| Aug 10, 2026 MForm 4 → | Aug 12, 7:33 pm EDT | David Malcom RodmanChief Medical Officer | 2,170 | — | — | 13,024 | — | 10b5-1 |
| Jul 21, 2026 MForm 4 → | Jul 23, 6:39 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | — | — | 245,438 | — | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 20, 9:00 pm EDT | David Malcom RodmanChief Medical Officer | 416 | — | — | 3,334 | — | 10b5-1 |
| Jul 13, 2026 MForm 4 → | Jul 15, 8:58 pm EDT | David Malcom RodmanChief Medical Officer | 14,058 | — | — | 0 | — | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 10, 7:15 pm EDT | David Malcom RodmanChief Medical Officer | 2,171 | — | — | 15,194 | — | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 6:41 pm EDT | Eric WarrenChief Commercial Officer | 104,124 | — | — | 252,876 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 17, 9:18 pm EDT | Daphne KarydasDirector | 3,000 | — | — | 38,000 | — | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 17, 9:18 pm EDT | David Malcom RodmanChief Medical Officer | 8,126 | — | — | 3,750 | — | 10b5-1 |
| Jun 10, 2026 MForm 4 → | Jun 12, 6:04 pm EDT | David Malcom RodmanChief Medical Officer | 8,519 | — | — | 6,349 | — | 10b5-1 |